Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0-5 years in Brazil

Nenhuma Miniatura disponível
Citações na Scopus
Tipo de produção
Data de publicação
Título da Revista
ISSN da Revista
Título do Volume
LUQUETTI, Alejandro O.
PRATA, Aluisio
ACTA TROPICA, v.117, n.1, p.10-13, 2011
Projetos de Pesquisa
Unidades Organizacionais
Some Latin American countries have plans for total control and/or eradication of Chagas disease by the main vector (Triatoma infestans) and by blood transfusion. To achieve this, patients with Chagas disease must be identified. A Western blotting test, TESAcruzi, is described as a supplemental test for diagnosis of Chagas disease using samples collected from children <5 years living in different states of Brazil. Blood samples collected by finger prick on filter paper were sent to the test laboratory by a central laboratory to confirm results obtained previously. Ten percent of negative samples, all doubtful and all positive samples were received. Commercial reagents, IgG indirect immunofluorescence, enzyme immunoassay, and a recently introduced TESAcruzi test were used. From 8788 samples, 163 (1.85%) were reactive by IgG-ELISA and 312 (3.55%) by IgG IIF. From these, 77 (0.87%) were reactive in the TESAcruzi test. The results had high clinical value to identify those truly infected.
Diagnosis, Chagas disease, TESAcruzi
  1. YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
  2. Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x
  3. Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001
  4. Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
  5. Gurtler RE, 2003, EMERG INFECT DIS, V9, P29
  6. Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143
  7. da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
  8. CAMARGO ME, 1984, REV I MED TROP, V26, P192
  9. DALANA M, 1998, EXP PARASITOL, V90, P20
  10. Guimarães M C, 1985, Bull Pan Am Health Organ, V19, P16
  11. LEWINSOHN R, 1979, T ROY SOC TROP MED H, V73, P513, DOI 10.1016/0035-9203(79)90042-7
  12. Luquetti AO, 2005, REV SOC BRAS MED TRO, V38, P27
  13. Marin-Neto JA, 2009, REV ESP CARDIOL, V62, P1211, DOI 10.1016/S0300-8932(09)73071-4
  14. Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
  15. Roddy P, 2008, J CLIN MICROBIOL, V46, P2022, DOI 10.1128/JCM.02303-07
  16. SOUZA SI, 1965, REV INST MED TROP SP, V8, P255
  17. Umezawa ES, 1996, J CLIN LAB ANAL, V10, P407, DOI 10.1002/(SICI)1098-2825(1996)10:6<407::AID-JCLA16>3.3.CO;2-9
  18. Villa L, 2007, MEM I OSWALDO CRUZ, V102, P87, DOI 10.1590/S0074-02762007005000081